Want to join the conversation?
Pharma company $AKRX said tax rate for 1Q16 was 37.1% and it expects the full year 2016 income tax rate to be approx. 37%. The company ended 1Q16 with $141MM in cash compared to $346MM at Dec. 31, 2015. $AKRX made a voluntary prepayment of $200MM against its term loan facility, leaving it approx. $832MM outstanding against its term loan facility.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?